Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
| 31.21 Delayed Data As of 3:59pm ET |  +0.035 / +0.11%Today’s Change | 24.63 Today|||52-Week Range 44.46 | +11.38% Year-to-Date |
Latest AMPH News | Press Releases
No recent news for Amphastar Pharmaceuticals Inc.
Today’s Trading
| Previous close | 31.18 |
| Today’s open | 31.08 |
| Day’s range | 31.08 - 31.74 |
| Volume | 3,199 |
| Average volume (3 months) | 215,035 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +4,262.75% |
| Earnings growth (this year) | +19.71% |
| Earnings growth (next 5 years) | +19.00% |
| Revenue growth (last year) | +25.13% |
| P/E ratio | 20.9 |
| Price/Sales | 2.65 |
| Price/Book | 3.27 |
Competitors
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | March 13, 2023 |
| EPS forecast (this quarter) | $0.40 |
| Annual revenue (last year) | $437.8M |
| Annual profit (last year) | $62.1M |
| Net profit margin | 14.19% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rancho Cucamonga, California |
Forecasts
